Description
Mirabegron (ER 50 mg)
Activates β3-adrenergic receptors in the detrusor muscle
Promotes bladder relaxation during the storage phase
Increases functional bladder capacity and reduces urinary frequency
Solifenacin Succinate (5 mg)
Blocks muscarinic receptors (M3 subtype) in the bladder
Reduces detrusor overactivity and involuntary contractions
Decreases urgency and urge incontinence episodes
Benefits of MIRATIME-50 Tablets
Improves bladder capacity and storage
Reduces urinary urgency and frequency
Controls urge incontinence episodes
Enhances quality of life for patients with overactive bladder
Convenient once-daily dosing
